D-0259-2022 Class II Terminated
FDA drug recall D-0259-2022 was initiated by Teligent Pharma, Inc. on Oct 19, 2021 and is designated Class II. Reason for recall: Defective Container The recall status is terminated (terminated Jun 18, 2024). Affected quantity: 5400 units.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 1, 2021
- Initiation Date
- Oct 19, 2021
- Termination Date
- Jun 18, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5400 units
Product description
Diclofenac Sodium Topical Solution USP, 1.5 w/w, 5 fl oz (150 mL) plastic bottles, Rx only, Teligent Pharma, Inc., Buena, New Jersey, 08310, NDC 70512-025-05.
Reason for recall
Defective Container
Distribution pattern
Nationwide within the United States
Code information
Lot #: 15028, Exp 1/2023; 15379, Exp 3/2023.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0259-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026